CD34 and acute myeloid leukemia: Future studies directed towards generation of gene expression profiles in the fraction of paediatric LSCs that have been functionally defined (whether these are exclusively within the CD34+/−CD38+/− subset or not) is warranted to further refine the gene expression score specific to paediatric AML, especially as the prognosis of paediatric AML is typically better than that of adult AML.